InvestorsHub Logo
Followers 7
Posts 509
Boards Moderated 0
Alias Born 02/01/2018

Re: None

Thursday, 05/16/2019 8:06:49 AM

Thursday, May 16, 2019 8:06:49 AM

Post# of 164009
So, I've been thinking about this revenue thing. Assuming the company at a minimum can almost break even with the Vytex, RxAir and FEC, they should be getting at least 4-5 million in profits from Rotman's per year to carry them, which should being the share price a lot higher. Now, in reality, from seeing the tweets about the RXAirs being shipped and the new mattresses coming out and Vytex being tested by different manufacturers and FEC being tested in dialysis clinics, I think it is more likely that the other divisions of Vystar will more than hold their own in the future.

Anything I say here is my opinion and not to be used to influence any investment decisions.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYST News